New compounds for the inhibition of angiogenesis and use of thereof

Details for Australian Patent Application No. 2005223356 (hide)

Owner Jerini AG

Inventors Knolle, Jochen; Hummel, Gerd; Zischinsky, Gunther; Osterkamp, Frank; Birkner, Sascha; Reineke, Ulrich; Zahn, Grit; Stragies, Roland

Agent Pizzeys

Pub. Number AU-B-2005223356

PCT Pub. Number WO2005/090329

Priority 04007067.4 24.03.04 EP

Filing date 24 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 17 May 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/090329 Priority application(s): WO2005/090329

17 May 2012 Application Accepted

  Published as AU-B-2005223356

9 August 2012 Alteration of Name

  The name of the applicant has been altered to Shire Orphan Therapies GmbH

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223360-Method for quantitatively determining specific constituting heparins or low molecular weight heparins using HPLC

2005223354-Process for the production of titanium dioxide